Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (63)	12/3/1997 8:34:00 PM
From: squetch	Read Replies (1) \| Respond to of 3044

Since nobody else appears to be hanging here: Do you like ONM? I took a quick look a few months ago and looked interesting. I wondered if INCY would be interested in them? My wife worked for ADI and we have some friends who work there still. Do follow that one? squetch

To: Pseudo Biologist who wrote (63)	12/9/1997 10:00:00 PM
From: biowa	Read Replies (1) \| Respond to of 3044

MPB et squetch, Anyone for a game of gin rummy? I had to come back after I saw you guys had degenerated to talking about telecommunications on the thread. Somebody had to make honest men out of you. Actually sorry for the hiatus, I've been very busy making money which has not been that easy in this sector the last few weeks so I had to go out and do it the old fashioned way...consulting <g>. As for Predictive Medicines group, my crystal ball says 1Q98. I suspect the deal may be on the cusp as I write but if it doesn't go out this week, why lose the PR in the second half of December. BTW, MLNM has undergone an internal reorganization to streamline operations, has either of you heard anything public on it? >>Back to topic, I found a little article on this pharmacogenomics area, the subtitle is "New, hot - but there is no it - yet" Cute, eh. Says genomics companies are looking to access the expertises of CROs (Contract Research Organizations), HMOs and hospital centers in order to make p-genomics work. P-genomics deals in 96/97 include those by Abbott and Frenh company Genset; the SmithKline-Incyte deal, the Spectra acquisition by Glaxo, deals by AFFX with Glaxo and with Oncormed, etc. Other firms listed as thinking that they can make a business in p-genomics are GENE, MLNM, and SQNA, and start-ups like Genaissance Pharmaceuticals and Nova Molecular. Another interesting start-up is Rosetta Inpharmatics out of Lee Hood's lab in U. Washington (Hood's technology was key for Applied Biosystems, now a unit of Perkin Elmer).<< Where'd you find this article, MPB, I'd like to dig it up. Whose deal is it? biowa